Mutual funds holding Aurobindo Pharma shares
127 mutual fund schemes held Aurobindo Pharma shares in their latest portfolios (October 2026, or September 2026 where a fund house's October 2026 portfolio is not yet in), worth about ₹11,462 cr in all. The largest holders by value are HDFC Mid Cap Fund (2.2% of the fund), Quant ELSS Tax Saver Fund (8.5% of the fund), Quant Mid Cap Fund (10.7% of the fund).
Against the month before, 2 schemes added Aurobindo Pharma as a new holding and 0 sold out of it completely.
New holders: Helios Mid Cap Fund, Helios Large & Mid Cap Fund
By category: Index Fund (45), Sectoral/Thematic (32), Large & Mid Cap (10), Mid Cap (9), Multi Cap (6), Arbitrage (6).
10 actively managed schemes holding it are rated A+ or A on their track record, among them Quant ELSS Tax Saver Fund, Quant Flexi Cap Fund, Quant Large & Mid Cap Fund, SBI Healthcare Opportunities Fund, Mirae Asset Healthcare Fund.
Every scheme holding Aurobindo Pharma, by value
| Scheme | Rating | % of fund | Value | Change |
|---|---|---|---|---|
| HDFC Mid Cap FundMid Cap | C | 2.19% | ₹2,205 cr | – |
| Quant ELSS Tax Saver FundELSS | A+ | 8.49% | ₹1,091 cr | – |
| Quant Mid Cap FundMid Cap | B | 10.71% | ₹804 cr | – |
| SBI Large & Midcap FundLarge & Mid Cap | C | 1.98% | ₹789 cr | +0.04 |
| Quant Multi Cap FundMulti Cap | C | 9.49% | ₹689 cr | – |
| SBI Midcap FundMid Cap | C | 2.29% | ₹510 cr | +0.11 |
| Quant Flexi Cap FundFlexi Cap | A | 6.87% | ₹494 cr | – |
| SBI Flexicap FundFlexi Cap | C | 1.74% | ₹376 cr | -1.29 |
| HDFC Large & Mid Cap FundLarge & Mid Cap | B | 1.27% | ₹357 cr | – |
| Quant Large & Mid Cap FundLarge & Mid Cap | A+ | 9.76% | ₹329 cr | – |
| UTI - Mid Cap FundMid Cap | C | 2.24% | ₹259 cr | – |
| SBI ELSS Tax Saver FundELSS | C | 0.84% | ₹251 cr | +0.00 |
| SBI Healthcare Opportunities FundSectoral/Thematic | A | 3.10% | ₹188 cr | -0.32 |
| SBI Dividend Yield FundDividend Yield | B | 2.33% | ₹182 cr | -0.16 |
| UTI Large & Mid Cap FundLarge & Mid Cap | B | 2.63% | ₹162 cr | – |
| SBI Arbitrage FundArbitrage | A+ | 0.35% | ₹161 cr | – |
| Quant Small Cap FundSmall Cap | B | 0.42% | ₹145 cr | – |
| SBI MNC FundSectoral/Thematic | B | 2.19% | ₹134 cr | -0.43 |
| Mirae Asset Healthcare FundSectoral/Thematic | A | 3.73% | ₹133 cr | -0.05 |
| Nippon India Pharma FundSectoral/Thematic | C | 1.42% | ₹129 cr | -0.23 |
| Nippon India Vision Large & Mid Cap FundLarge & Mid Cap | C | 1.59% | ₹117 cr | +0.02 |
| quant Momentum FundSectoral/Thematic | – | 9.34% | ₹114 cr | – |
| quant Quantamental FundSectoral/Thematic | B | 7.27% | ₹109 cr | – |
| quant Business Cycle FundSectoral/Thematic | B | 10.38% | ₹93 cr | – |
| Quant Value FundValue / Contra | B | 4.32% | ₹80 cr | – |
| Axis ELSS- Tax Saver FundELSS | B | 0.24% | ₹73 cr | – |
| quant Manufacturing FundSectoral/Thematic | B | 9.94% | ₹67 cr | – |
| UTI Focused Fund (30 stocks)Focused | B | 2.79% | ₹65 cr | – |
| SBI Quant FundSectoral/Thematic | – | 2.49% | ₹63 cr | +0.05 |
| SBI Contra FundValue / Contra | B | 0.13% | ₹58 cr | -0.05 |
| Aditya Birla Sun Life Pharma and Healthcare FundSectoral/Thematic | C | 4.52% | ₹49 cr | – |
| Motilal Oswal Nifty Midcap 150 Index FundIndex Fund | B | 1.19% | ₹47 cr | +0.05 |
| Nippon India Arbitrage FundArbitrage | B | 0.24% | ₹43 cr | – |
| Helios Mid Cap FundMid Cap | – | 1.77% | ₹43 cr | new |
| Kotak Active Momentum FundSectoral/Thematic | – | 2.67% | ₹41 cr | – |
| Bank Of India Mid Cap FundMid Cap | – | 5.73% | ₹40 cr | – |
| UTI - MNC FundSectoral/Thematic | B | 1.58% | ₹40 cr | – |
| quant Healthcare FundSectoral/Thematic | A | 9.61% | ₹40 cr | – |
| Edelweiss Nifty Midcap150 Momentum 50 Index FundIndex Fund | B | 2.35% | ₹40 cr | – |
| Bajaj Finserv Multi Cap FundMulti Cap | – | 2.40% | ₹39 cr | – |
And 87 more schemes with smaller holdings.
Value: the scheme's assets under management × the stock's weight, approximate. Change: the weight against the previous month's portfolio, in percentage points; it moves with the share price as well as with buying and selling. Links go to each scheme's Regular plan.
Common questions
How many mutual funds hold Aurobindo Pharma shares?
127 schemes held Aurobindo Pharma in their latest monthly portfolios (October 2026, or September 2026 where a fund house's October 2026 portfolio is not yet in), worth about ₹11,462 cr in all.
Which mutual fund holds the most Aurobindo Pharma shares?
By value, HDFC Mid Cap Fund: about ₹2,205 cr, 2.19% of the fund.
Where does this data come from?
From the monthly portfolios that every fund house must publish by the 10th of the following month. Values are approximate: the fund's assets under management multiplied by the stock's weight in the portfolio.
This page lists which funds hold a stock. It is not a view on the stock or a recommendation to buy or sell it or any fund. Ratings describe past track records, not a forecast.
Send us your CAS and get a written report: which of your funds to keep, which to exit and when, where new SIPs should go, and what each change costs in tax.